Synthesis and <sup>177</sup>Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant-Reference-Cited by-同舟云学术

Synthesis and ¹⁷⁷Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant

Published:2023-06-28 Issue:9 Volume:34 Page:1576-1584
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Sharma Amit Kumar¹²,Sharma Rohit¹²,Das Amit³²,Chakraborty Avik⁴²,Rakshit Sutapa⁴,Sarma Haladhar Dev³,Mukherjee Archana¹²,Das Tapas¹²^ORCID,Satpati Drishty¹²^ORCID

Affiliation:

1. Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India

2. Homi Bhabha National Institute, Mumbai 400094, India

3. Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India

4. Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400012, India

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.3c00265

Reference28 articles.

1. The future of peptides in cancer treatment

2. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

3. Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

4. Peptides as Carrier for Tumor Diagnosis and Treatment

5. Peptides for optical medical imaging and steps towards therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 177Lu-labeling of nuclear localization sequence (NLS)-grafted HER2-receptor affine peptide;Bioorganic & Medicinal Chemistry;2024-10

2. Peptide‐drug conjugate designated for targeted delivery to HER2‐expressing cancer cells;Journal of Peptide Science;2024-04-10